| 产品名称： | Mycobacterium porcinum Tsukamura et al. |
|---|---|
| 商品货号： | TS193270 |
| Deposited As： | Mycobacterium fortuitum da Costa Cruz |
| Strain Designations： | MF 661 W6234 |
| Isolation： | Tissue, human Lafayette Louisiana, United States |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Preceptrol®： | no |
| Type Strain： | no |
| Comments： | Third biovariant complex |
| Medium： | ATCC® Medium 18: Trypticase Soy Agar/Broth |
| Growth Conditions： | Temperature: 35.0°C |
| Name of Depositor： | RJ Wallace |
| Chain of Custody： | ATCC < |
| References： | Wallace RJ J, et al. Clinical disease, drug susceptibility, and biochemical patterns of the unnamed third biovariant complex of Mycobacterium fortuitum. J. Infect. Dis. 163: 598-603, 1991. PubMed: 1995732 Schinsky MF, et al. Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of Mycobacterium boenickei sp. nov., Mycobacterium houstonense sp. nov., Mycobacterium neworleansense sp. nov. and Mycobacterium brisbanense sp. nov. and recognition of Mycobacterium porcinum from human clinical isolates.. Int. J. Syst. Evol. Microbiol. 54: 1653-1667, 2004. PubMed: 15388725 back wound, Lafayette, LA |
| Cross References： | Nucleotide (GenBank) : AY012580 Mycobacterium porcinum strain W6234 16S ribosomal RNA gene, partial sequence. |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Mycobacterium porcinum Tsukamura et al. |
|---|---|
| 商品货号： | TS193270 |
| Deposited As： | Mycobacterium fortuitum da Costa Cruz |
| Strain Designations： | MF 661 W6234 |
| Isolation： | Tissue, human Lafayette Louisiana, United States |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Preceptrol®： | no |
| Type Strain： | no |
| Comments： | Third biovariant complex |
| Medium： | ATCC® Medium 18: Trypticase Soy Agar/Broth |
| Growth Conditions： | Temperature: 35.0°C |
| Name of Depositor： | RJ Wallace |
| Chain of Custody： | ATCC < |
| References： | Wallace RJ J, et al. Clinical disease, drug susceptibility, and biochemical patterns of the unnamed third biovariant complex of Mycobacterium fortuitum. J. Infect. Dis. 163: 598-603, 1991. PubMed: 1995732 Schinsky MF, et al. Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of Mycobacterium boenickei sp. nov., Mycobacterium houstonense sp. nov., Mycobacterium neworleansense sp. nov. and Mycobacterium brisbanense sp. nov. and recognition of Mycobacterium porcinum from human clinical isolates.. Int. J. Syst. Evol. Microbiol. 54: 1653-1667, 2004. PubMed: 15388725 back wound, Lafayette, LA |
| Cross References： | Nucleotide (GenBank) : AY012580 Mycobacterium porcinum strain W6234 16S ribosomal RNA gene, partial sequence. |
